Healthcare & Life Sciences
Your 'Triangle' for the Healthcare and Life Sciences segment in Asia.
At the heart of our Executive Search success is our 'Triangle-Team', uniting three specialized dimensions for each project. This team brings together a wealth of knowledge and insight, tailored for the Healthcare and Life Sciences segment in the Asian markets.
Mr. Nishlank Jain
Mr. David Liendgens
Mr. Sven Henrichwark
Methodology & Assessment Lead: David brings over a decade of expertise in executive search and diagnostics. As the process leader, he supports each assignment with a focus on rigorous assessment and sophisticated methodology. His approach is meticulous, ensuring search processes are finely tailored and aligned with organizational needs. With a rich background in consulting, David understands the complexities of executive search. He excels in working collaboratively with clients to pinpoint essential competencies while striving to reduce bias in the recruitment process.
Candidate Engagement & Market Researcher: Nishlank, known for his strategic research and candidate engagement, provides the essential link between potential candidates and our clients' needs. His adept use of executive outreach and professional networking positions him as a key asset in the discovery and engagement of exceptional talent. Nish's experience in crafting detailed search strategies ensures a comprehensive approach to each search process, underpinning the success of our placements with a thorough understanding of both the market and the candidates.
Industry-Advisor: Sven Henrichwark, a key member of our executive panel, brings over 20 years of expertise in the biotech, life science, and medical device sectors to the table. His vast experience, especially in Asian markets, is integral to our commitment to embedding strong industry knowledge into each search. Sven's career, highlighted by leadership roles in the US, Europe, and Asia, has been distinguished by his strategic approach and dedication to collective success. He has driven growth, managed market entries, and revitalized divisions, notably in Asia. Currently, as CEO of Fibronostics and Operating Partner at Ampersand, he's pioneering AI-driven diagnostics and growth equity-focussed investments in Asia.